Search by Drug Name or NDC

    NDC 70860-0407-10 Tranexamic Acid 100 mg/mL Details

    Tranexamic Acid 100 mg/mL

    Tranexamic Acid is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Athenex Pharmaceutical Division, LLC.. The primary component is TRANEXAMIC ACID.

    Product Information

    NDC 70860-0407
    Product ID 70860-407_a96c3507-728b-4f48-9f8d-65067c6a8fbe
    Associated GPIs
    GCN Sequence Number 068183
    GCN Sequence Number Description tranexamic acid VIAL 1000 MG/10 INTRAVEN
    HIC3 M9D
    HIC3 Description ANTIFIBRINOLYTIC AGENTS
    GCN 30912
    HICL Sequence Number 002802
    HICL Sequence Number Description TRANEXAMIC ACID
    Brand/Generic Generic
    Proprietary Name Tranexamic Acid
    Proprietary Name Suffix n/a
    Non-Proprietary Name tranexamic acid
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 100
    Active Ingredient Units mg/mL
    Substance Name TRANEXAMIC ACID
    Labeler Name Athenex Pharmaceutical Division, LLC.
    Pharmaceutical Class Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA203521
    Listing Certified Through n/a

    Package

    NDC 70860-0407-10 (70860040710)

    NDC Package Code 70860-407-10
    Billing NDC 70860040710
    Package 10 VIAL, SINGLE-DOSE in 1 CARTON (70860-407-10) / 10 mL in 1 VIAL, SINGLE-DOSE (70860-407-41)
    Marketing Start Date 2022-09-22
    NDC Exclude Flag N
    Pricing Information N/A